ETHRIS
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.
Tech Stack (4 technologies)
Frequently Asked Questions
What technologies does ETHRIS use?+
ETHRIS uses 4 technologies including AngularJS, Cloudflare Turnstile, Apache HTTP Server.
What industry is ETHRIS in?+
ETHRIS operates in the Bioinformatics industry.
Where is ETHRIS based?+
ETHRIS is headquartered in Germany.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026